2020
DOI: 10.1107/s2056989020004077
|View full text |Cite
|
Sign up to set email alerts
|

Norpsilocin: freebase and fumarate salt

Abstract: The solid-state structures of the naturally occurring psychoactive tryptamine norpsilocin {4-hydroxy-N-methyltryptamine (4-HO-NMT); systematic name: 3-[2-(methylamino)ethyl]-1H-indol-4-ol}, C11H14N2O, and its fumarate salt (4-hydroxy-N-methyltryptammonium fumarate; systematic name: bis{[2-(4-hydroxy-1H-indol-3-yl)ethyl]methylazanium} but-2-enedioate), C11H15N2O+·0.5C4H2O4 2−, are reported. The freebase of 4-HO-NMT has a single molecule in the asymmetric unit joined together by N—H...O and O—H… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
12
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
8

Relationship

7
1

Authors

Journals

citations
Cited by 12 publications
(12 citation statements)
references
References 20 publications
0
12
0
Order By: Relevance
“…53 This biotransformation reaction probably also occurs with secondary amines like 4-acetoxy-N-methyltryptamine (4-AcO-NMT) and quaternary ammoniums like 4acetoxy-N,N,N-trimethyltryptamine (4-AcO-TMT), the synthetic analogues of baeocystin and aeruginascin. 41,43,54 Importantly, psilacetin is less potent than psilocin in producing psychedelic-like effects in rodents, 52,55 which is consistent with the expected profile of a prodrug. As with the other constituents of psilocybin-containing mushrooms, the pharmacology of 4-acetoxy analogues of psilocybin, baeocystin, and aeruginascin is largely uncharacterized, and a side-by-side comparison of the natural products and their corresponding active metabolites has not been performed.…”
mentioning
confidence: 53%
See 1 more Smart Citation
“…53 This biotransformation reaction probably also occurs with secondary amines like 4-acetoxy-N-methyltryptamine (4-AcO-NMT) and quaternary ammoniums like 4acetoxy-N,N,N-trimethyltryptamine (4-AcO-TMT), the synthetic analogues of baeocystin and aeruginascin. 41,43,54 Importantly, psilacetin is less potent than psilocin in producing psychedelic-like effects in rodents, 52,55 which is consistent with the expected profile of a prodrug. As with the other constituents of psilocybin-containing mushrooms, the pharmacology of 4-acetoxy analogues of psilocybin, baeocystin, and aeruginascin is largely uncharacterized, and a side-by-side comparison of the natural products and their corresponding active metabolites has not been performed.…”
mentioning
confidence: 53%
“…More recently, psilacetin has emerged as a popular new psychoactive substance (NPS) on recreational drug markets, where it is sold as a psilocybin alternative. Analogous to the metabolism of psilocybin to psilocin, 4-acetoxy compounds are thought to hydrolyze to their corresponding 4-hydroxy compounds. ,, While definitive biotransformation studies in animals are lacking, in vitro evidence from liver microsomes supports the metabolic conversion of 4-acetoxy compounds to their 4-hydroxy analogues . This biotransformation reaction probably also occurs with secondary amines like 4-acetoxy- N -methyltryptamine (4-AcO-NMT) and quaternary ammoniums like 4-acetoxy- N , N , N -trimethyltryptamine (4-AcO-TMT), the synthetic analogues of baeocystin and aeruginascin. ,, Importantly, psilacetin is less potent than psilocin in producing psychedelic-like effects in rodents, , which is consistent with the expected profile of a prodrug. As with the other constituents of psilocybin-containing mushrooms, the pharmacology of 4-acetoxy analogues of psilocybin, baeocystin, and aeruginascin is largely uncharacterized, and a side-by-side comparison of the natural products and their corresponding active metabolites has not been performed.…”
mentioning
confidence: 99%
“…The title compound is similar to that of other 5-O-substituted tryptamines whose structures have been reported, including bufotenine (BUFTEN: Falkenberg, 1972a), melatonin (MELATN: Wakahara et al, 1972), 5-MeO-DMT hydrochloride (MOTYPT: Falkenberg & Carlströ m, 1971), 5-methoxytryptamine (MXTRUP: Quarles et al, 1974), 5-MeO-DMT and 5-methoxymonomethyltryptamine (QQQAGY & QQQAHA: Bergin et al, 1968). The structure is also similar to the freebases of other psychedelic tryptamines that have been reported, including psilocybin (PSILOC: , psilocin (PSILIN: , N,N-dimethyltryptamine (DMTRYP: Falkenberg, 1972b), N-methyl-N-propyltryptamine (WOHYAW: Chadeayne, et al 2019) and norpsilocin (Chadeayne et al, 2020).…”
mentioning
confidence: 65%
“…and norpsilocin(CCDC 1992279;Chadeayne et al, 2020b), and the synthetic psychedelic N-methyl-N-n-propyltryptamine (WOHYAW;Chadeayne et al, 2019b). The other fumarate salts of tryptamines known are norpsilocin(CCDC 1992278;Chadeayne et al, 2020b), 4-hydroxy-N-methyl-N-isopropyltryptamine(CCDC 1962339;Chadeayne et al, 2020a), 5-methoxy-2,N,N-trimethyltryptamine and psilacetin (HOCJUH;Chadeayne et al, 2019a).…”
mentioning
confidence: 99%